Responses
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Compose a Response to This Article
Other responses
No responses have been published for this article.